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Abstract 34 
  Vibrio cholerae O1 El Tor variant strains produced much more cholera toxin than 35 
that produced by prototype El Tor strains. The amount of cholera toxin produced by El 36 
Tor variant strains both in vitro and in vivo was more or less equivalent to that produced 37 
by classical strains. 38 
 39 
 40 
  Vibrio cholerae O1 is classified into classical and El Tor biotypes. Among other 41 
genetic, biochemical and physiological differences, each biotype has unique gene 42 
sequences encoding cholera toxin B subunit (CTB), that is, classical ctxB and El Tor 43 
ctxB. Besides these two prototype biotypes of V. cholerae O1, Nair et al. (9) in 2002 in 44 
Bangladesh isolated strains that possess phenotypic properties of both classical and El 45 
Tor biotype carrying classical ctxB. The same group also isolated El Tor strains that had 46 
classical ctxB (10). For these new types of strains of V. cholerae O1, we have recently 47 
proposed the designation of hybrid and El Tor variants, respectively (13). Subsequent to 48 
the isolation of El Tor variant in Bangladesh by Nair et. al. (10), El Tor variant strains 49 
were isolated from several countries and areas in Asia and Africa (1, 11, 15-18). In 50 
Kolkata, India, we showed that El Tor variant strains appeared in 1990 and a complete 51 
replacement of prototype El Tor strains by El Tor variant strains occurred since 1995 52 
(14).  53 
  In this study, we investigated the amount of cholera toxin (CT) produced both in vitro 54 
and in vivo by V. cholerae O1 El Tor variant strains isolated in Kolkata during a period 55 
from 1996 to 2007. It was found that El Tor variant strains produced much higher 56 
amount of CT than prototype El Tor strains and that the amount of CT produced by El 57 
Tor variant strains was more or less equivalent to that produced by classical strains. 58 
  V. cholerae O1 strains used in this study are listed in Table 1. AKI (3) and Syncase 59 
medium (2) were used for culturing the test strains. The rationale for selecting these 60 
media was that AKI preferentially supports the production of El Tor CT (3) while 61 
Syncase medium is reported to be the best medium supporting the production of CT by 62 
classical biotype (2). Measurement of CT concentration produced by V. cholerae O1 63 
strain was carried out as follows. Each strain was cultured either in AKI medium at 64 
37oC for 20 hours without shaking or in Syncase medium at 37oC for 20 hours with 65 
shaking, and OD of the culture was measured at 600 nm. After centrifugation, the 66 
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supernatants were collected and the concentration of CT (ng/ml/OD600) in the samples 67 
was measured by bead-ELISA. The method of the bead-ELISA employed was 68 
essentially as described by Oku et al. (12). In brief, a polystyrene bead (6.5 mm in 69 
diameter) was coated with anti-CT IgG and used as a solid phase. The coated bead was 70 
first incubated with the sample, and then incubated with anti-CT IgG (Fab’)-horseradish 71 
peroxidase conjugate. Peroxidase activity was determined colorimetrically with 3, 3’, 5, 72 
5’-tetramethylbenzidine as the substrate. The absorbance at 450 nm (OD450) was linear 73 
between 0 and 0.5 that represented CT concentration of 0 – 20 ng/ml. The sample 74 
prepared as described above (the supernatant of the culture of the strain) was 75 
appropriately diluted so that the OD450 fell in the range of 0.1 and 0.5 and the amount of 76 
CT produced by the strain was expressed by ng/ml/OD600. 77 
 Rabbit ileal loop test was carried out essentially as described by Koley et al. (7). Eight 78 
intestinal loops of about 10 cm, separated by uninoculated segments of 1-2 cm, were 79 
prepared in each animal. Test loops were inoculated with 1 ml of bacterial suspension 80 
containing approximately 109 cells. Negative control loops were inoculated with 1 ml of 81 
phosphate buffered saline. The loops were replaced in the peritoneal cavity and the 82 
cavity was closed. After about 20 hours the animal was sacrificed by intravenous 83 
injection of sodium pentobarbital and the loops were taken out. The volume of the 84 
accumulated fluid in ml and the length of the loop in cm were measured and the extent 85 
of the fluid accumulation (FA) was expressed by ml/cm. 86 
  All 19 strains of V. cholerae O1 El Tor variant belonged to the El Tor biotype as 87 
evident from phenotypic traits such as resistance to 50 units of polymyxin B and 88 
positive Voges-Proskauer test (19). All harbored El Tor biotype specific alleles of tcpA 89 
and rstR when examined as described (5, 6). The ctxB gene of all strains was of 90 
classical type by mismatch amplification mutation assay (MAMA)-PCR carried out as 91 
described by Morita et al. (8). Further, the CTB produced by all strains was confirmed 92 
to be the classical type by Western blotting by using monoclonal antibody against either 93 
classical CTB or El Tor CTB, which was prepared by immunizing rats with synthesized 94 
peptide (either NTQIYTLNDKC for El Tor CTB and NTQIHTLNDKC for classical 95 
CTB). Approximately 50-100 ng of CT (measured by bead ELISA) in the culture 96 
supernatant of each strain were analyzed. The result of the Western blotting of a 97 
representative strain (strain AM157) is shown in Fig. 1.  98 
  Fig. 2 shows the distribution of the amount of CT produced by strains examined. 99 
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Each strain of El Tor variant, prototype El Tor and classical biotype was cultured in 2 100 
ml of AKI medium in 10 ml test tube at 37oC for 20 hours without shaking, the 101 
supernatant of the culture was collected by centrifugation and was measured to 102 
determine the amount of CT by the bead-ELISA. It was found that most strains of El 103 
Tor variant produced much more CT than most strains of prototype El Tor strains. All 104 
19 El Tor variant strains produced more than 1,000 ng/ml/OD600 of CT and among them 105 
5 strains (AM157, 06-049, IDH60, BD200 and 06-098) produced more than 2,500 106 
ng/ml/OD600, the highest (strain AM157) producing 4,656 ng/ml/OD600. The amount of 107 
CT produced varied, but was not related to the year of the isolation. Among 11 El Tor 108 
strains, 8 strains (V113, VC60, M14716, V7, VC64, V54, V24, V32) produced less than 109 
100 ng/ml/OD600, and among them 3 strains (V54, V24, V32) produced less than 20 110 
ng/ml/OD600. Rest of the strains (N16961, V100, V114) produced more than 100 111 
ng/ml/OD600 and the standard strain N16961 produced the highest amount (345 112 
ng/ml/OD600). All 7 classical strains produced more than 900 ng/ml/OD600 and 2 of them 113 
(L362 and GP15) more than 2,000 ng/ml/OD600, the highest being L362 (3,028 114 
ng/ml/OD600).  115 
 The amount of CT produced was measured during the growth of the strains in AKI 116 
medium with the representative strains of El Tor variant, prototype El Tor and classical 117 
biotype and it was found that the difference of the amount of CT produced among these 118 
3 biotypes were observed from the beginning of the growth (early logarithmic phase) till 119 
the late stationary phase (data not shown). 120 
 Table 2 shows the mean CT amount produced by the strains of different biotypes with 121 
standard deviations. The amount of CT produced by El Tor variant strains was about 20 122 
times more than that produced by prototype El Tor strains, and it was more or less 123 
equivalent to that produced by classical strains. A difference of the CT production 124 
between El Tor variant strains and prototype El Tor strains was statistically analyzed by 125 
Microsoft Excel 2004 for Mac, the p-value being <0.05.	 126 
	 	 CT production by strains of El Tor variant, El Tor and classical biotype were also 127 
examined when they were cultured in Syncase medium (2 ml in 10 ml test tube) at 37oC 128 
for 20 hours with shaking. As shown in Table 2, although the amount of CT produced in 129 
Syncase medium was much less than those produced in AKI medium, El Tor variant 130 
strains produced much more CT than that produced by El Tor strains, and more or less 131 
equivalent to that produced by classical strains. The p-value of the difference of the 132 
 5 
amount produced between El Tor variant strains and prototype El Tor strains analyzed  133 
by Microsoft Excel 2004 for Mac was <0.05.  134 
  Ileal loop test was performed with a representative strain of El Tor variant (strain 135 
NLC41 producing 1,606 ng/ml/OD600 in AKI medium) together with representative 136 
strains of El Tor biotype (VC60 producing 60 ng/ml/OD600 in AKI medium) and   137 
classical biotype (L362 producing 3,028 ng/ml/OD600 in AKI medium). As shown in 138 
Table 3, FA ratio of the El Tor variant NLC41 was almost the same to that of classical 139 
strain L362. On the other hand, El Tor strain VC60 did not cause measurable fluid 140 
accumulation. This is most probably number of inoculated cells were not enough. 141 
Number of V. cholerae in the accumulated fluid (cfu/ml) and the amount of CT in the 142 
loop (ng/ml and ng/cfu) were also measured, showing that the El Tor variant strain grew 143 
better than the classical strain in the loop, thus the amount of CT in the loop inoculated 144 
with El Tor variant strain was higher than that with the classical strain. Measurement of 145 
cfu/ml of the accumulated fluid of the prototype of El Tor strains was not possible as no 146 
fluid accumulation occurred. 147 
  It is known that clinical manifestation of cholera caused by classical strains is more 148 
severe than that caused by prototype El Tor strains (4). Although a definite evidence to   149 
explain this is still not available, it has been hypothesized that a significant difference 150 
between the amounts of CT produced by these two biotype strains may reflect severity 151 
of clinical manifestation. If we would accept the above hypothesis, a recent report by 152 
World Health Organization (20) that V. cholerae El Tor variant causes more severe 153 
episodes of cholera with higher case fatality rates might be explained by the results 154 
reported in this paper. However, Siddique et al. (16) reported that although El Tor 155 
variant strains appeared in 1998 in Bangladesh, severity of cholera became evident 156 
since around 2006. Therefore they concluded that it is not clear whether the observed 157 
higher proportion of severe dehydration is due to El Tor variants. Further study is 158 
needed to elucidate the role of CT produced by El Tor variant strains in the clinical 159 
manifestation in its infection.    160 
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Legend to Figures 251 
 252 
Fig. 1. A result of Western blotting of the culture supernatant of a representative strain of 253 
El Tor variant biotype. Lane 1 and 6: 100 ng of the purified classical CT; Lane 2 and 7: 254 
100 ng of the purified El Tor CT; Lane 3 and 8: sample of El Tor variant strain AM157; 255 
Lane 4 and 9; sample of El Tor strain N16961; Lane 5 and 10; sample of classical strain 256 
L362. Panel A: results with the monoclonal antibody against classical CTB; Panel B: 257 
results with the monoclonal antibody against El Tor CTB. 258 
 259 
Fig. 2. Amount of CT produced by various biotypes of V. cholerae O1. Each circle 260 
represents an average of 4 determinations.  261 
262 
 10 
Table 1. V. cholerae O1 strains used. 263 
El Tor varianta 
  AM157 (1996)b, 06-049 (2006), IDH60 (2007), BD200 (2002), 06-098 (2006), 
  CRC220 (2000), AM168 (1996), DO2669 (1998), NLC96 (1999), CRC17 (2000),  
  AM352 (1997), NLC41 (1999), NLC49 (1999), D26942 (1998), SC32 (2003), 
  G27875 (2001), IDH32 (2007), SC216 (2003), NLC8 (1999) 
El Tora 
  N16961, V100, V114, V113, VC60, M14716, V7, VC64, V54, V24, V32 
Classicala 
  L362, GP15, GP8, GP148, GP147, 569B, GP145  
aStrains used are listed in the order of the CT production (from high to low). 264 
bThe year of the isolation is in parenthesis.             265 
266 
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Table 2. Comparison of the amount of CT produced by strains of various biotypes of V. 267 
cholerae O1a. 268 
Culture medium 
	 	 	 	 	 CT concentration (ng/ml/OD600) 
El Tor variant El Tor Classical 
AKI 2044.1 ± 966.8 91.3 ± 104.6 1664.4 ± 782.0 
Syncase 81.3 ± 147.2 4.5 ± 3.7b 114.7 ± 188.8 
a Strains examined were as listed in Table 1 unless indicated. 269 
b Only 5 strain of El Tor biotype (N16961, V113, VC64, VC60, V24) grew in Syncase 270 
 medium cultured at 37oC with shaking. 271 
272 
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Table 3. Results of rabbit ileal loop testa. 273 
Biotype Strain FA (ml/cm)a  CFU/mlb CT (ng/ml)a CT (ng/CFU) 
El Tor variant NLC41 0.90 ± 0.29 1.0 x 109 1006 1.006 x 10-6 
El Tor VC60 0 -c - - 
Classical L362 0.83 ± 0.38 1.6 x 108 17.5 1.09 x 10-7 
a An average of 4 determinations (2 loops each in 2 rabbits). Statystical analysis was 274 
 performed by Microsoft Excel 2004 for Mac. 275 
b An average of 2 determinations (2 loops of 1 representative rabbit) 276 
c Not applicable as no fluid accumulation occurred. 277 
278 
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